These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9928071)

  • 1. The effect of vasoactive intestinal polypeptide and pituitary adenylate cyclase activating polypeptide on tolerance to morphine and alcohol in mice.
    Szabó G; Mácsai M; Schek E; Telegdy G
    Ann N Y Acad Sci; 1998 Dec; 865():566-9. PubMed ID: 9928071
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of endotoxin-induced macrophage chemokine production by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in vitro and in vivo.
    Delgado M; Ganea D
    J Immunol; 2001 Jul; 167(2):966-75. PubMed ID: 11441105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of PACAP in the regulation of gonadotroph hormone secretion during ontogenesis: a single neonatal injection of PACAP delays puberty and its intracerebroventricular administration before the critical period of proestrous stage blocks ovulation in adulthood.
    Köves K; Molnár J; Kántor O; Lakatos A; Fógel K; Kausz M; Vandermeers-Piret MC; Somogyvári-Vigh A; Arimura A
    Ann N Y Acad Sci; 1998 Dec; 865():590-4. PubMed ID: 9928075
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of pituitary adenylate cyclase-activating polypeptide on acute and chronic morphine actions in mice.
    Mácsai M; Pataki I; Tóth G; Szabó G
    Regul Pept; 2002 Nov; 109(1-3):57-62. PubMed ID: 12409215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary adenylate cyclase activating polypeptide enhances rapid eye movement sleep in rats.
    Fang J; Payne L; Krueger JM
    Brain Res; 1995 Jul; 686(1):23-8. PubMed ID: 7583267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase of prolactin mRNA in the rat hypothalamus after intracerebroventricular injection of VIP or PACAP.
    Bredow S; Kacsóh B; Obál F; Fang J; Krueger JM
    Brain Res; 1994 Oct; 660(2):301-8. PubMed ID: 7820699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studies.
    Delgado M; Pozo D; Martinez C; Leceta J; Calvo JR; Ganea D; Gomariz RP
    J Immunol; 1999 Feb; 162(4):2358-67. PubMed ID: 9973516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6.
    Delgado M; Martinez C; Pozo D; Calvo JR; Leceta J; Ganea D; Gomariz RP
    J Immunol; 1999 Jan; 162(2):1200-5. PubMed ID: 9916753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perfusion of the paraventricular nucleus with pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide stimulates local release of norepinephrine and its metabolite: microdialysis study in freely moving rats.
    Huang Q; Légrádi G; Arimura A
    Ann N Y Acad Sci; 1996 Dec; 805():737-42. PubMed ID: 8993470
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibitory effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) on food intake in the goldfish, Carassius auratus.
    Matsuda K; Maruyama K; Nakamachi T; Miura T; Uchiyama M; Shioda S
    Peptides; 2005 Sep; 26(9):1611-6. PubMed ID: 16112400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intracerebroventricular administration of pituitary adenylate cyclase-activating polypeptide (PACAP) on the motor activity and reserpine-induced hypothermia in murines.
    Masuo Y; Noguchi J; Morita S; Matsumoto Y
    Brain Res; 1995 Nov; 700(1-2):219-26. PubMed ID: 8624713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoactive intestinal polypeptide induces analgesia and impairs the antinociceptive effect of morphine in mice.
    Mácsai M; Szabó G; Telegdy G
    Neuropeptides; 1998 Dec; 32(6):557-62. PubMed ID: 9920454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide on mouse preantral follicle development in vitro.
    Cecconi S; Rossi G; Barberi M; Scaldaferri L; Canipari R
    Endocrinology; 2004 Apr; 145(4):2071-9. PubMed ID: 14701671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anorexigenic effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide in the chick brain are mediated by corticotrophin-releasing factor.
    Tachibana T; Saito ES; Takahashi H; Saito S; Tomonaga S; Boswell T; Furuse M
    Regul Pept; 2004 Aug; 120(1-3):99-105. PubMed ID: 15177926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pituitary adenylate cyclase-activating polypeptide 38 (PACAP38) on tissue oxygen content--treatment in central nervous system of mice.
    Ohtaki H; Dohi K; Yofu S; Nakamachi T; Kudo Y; Endo S; Aruga T; Goto N; Watanabe J; Kikuyama S; Shioda S
    Regul Pept; 2004 Dec; 123(1-3):61-7. PubMed ID: 15518894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC.
    Jamen F; Puech R; Bockaert J; Brabet P; Bertrand G
    Endocrinology; 2002 Apr; 143(4):1253-9. PubMed ID: 11897681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells.
    Cai Y; Xin X; Shim GJ; Mokuno Y; Uehara H; Yamada T; Agui T; Matsumoto K
    Endocrinology; 1997 Jun; 138(6):2515-20. PubMed ID: 9165043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells.
    Nagakawa O; Junicho A; Akashi T; Koizumi K; Matsuda T; Fuse H; Saiki I
    Oncol Rep; 2005 Jun; 13(6):1217-21. PubMed ID: 15870945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.